Hennigsdorf, Germany Clinical Trials

A listing of Hennigsdorf, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma

This study is being conducted to test the safety and efficacy of ramucirumab in combination with other chemotherapy in the treatment of relapsed, recurrent, or refractory synovial sarcoma (SS) in children and young adults. This trial is part of the CAMPFIRE master protocol which is a platform to accelerate the …

Charit Universit tsmedizin Berlin
 (8.8 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +67 other locations
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

The purpose of this study is to assess the safety and efficacy profile of increasing doses of IPN10200 in comparison to placebo, with the aim to discover the doses(s) that offer the best efficacy/safety profile when used for the treatment of moderate to severe Upper Facial Lines. This study will …

CRS Clinical Research Services Berlin GmbH
 (8.8 away) Contact site
  • 0 views
  • 28 Apr, 2021
  • 1 location
INCB001158 Combined With Subcutaneous (SC) Daratumumab Compared to Daratumumab SC in Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the safety and antitumor activity of INCB001158 in combination with daratumumab SC, compared with daratumumab SC alone, in participants with relapsed or refractory multiple myeloma.

Charite - Universit tsmedizin Berlin
 (8.8 away) Contact site
  • 20 views
  • 03 Feb, 2021
  • +44 other locations
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

This study is being conducted to test the safety and efficacy of ramucirumab in combination with other chemotherapy in the treatment of relapsed, recurrent, or refractory desmoplastic small round cell tumor (DSRCT) in children and young adults. This trial is part of the CAMPFIRE master protocol which is a platform …

kidney function tests
cancer chemotherapy
measurable disease
vinorelbine
immunomodulators
Charit Universit tsmedizin Berlin
 (8.8 away) Contact site
  • 3 views
  • 19 Jun, 2021
  • +69 other locations
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)

immunosuppression
cell transplantation
ibrutinib
Charite-Universitaetsmedizin Berlin
 (8.8 away) Contact site
  • 47 views
  • 24 Jan, 2021
  • +49 other locations
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors

This study is to assess the safety and tolerability, and to assess the preliminary clinical benefit of NKTR-214 when combined with pembrolizumab (KEYTRUDA) with or without chemotherapy. The study is comprised of two groups; dose optimization and dose expansion cohorts. Dose Optimization will include first-line and second-line melanoma, non-small cell …

carcinoma
proto-oncogene tyrosine-protein kinase ros
nktr-214
lung cancer
epidermal growth factor
Investigator Site
 (5.9 away) Contact site
  • 1682 views
  • 04 Jun, 2021
  • +66 other locations
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

The primary objective of this study now is to assess the anti-neoplastic activity of flotetuzumab in patients with PIF/ER AML, as determined by the proportion of patients who achieve complete remission (CR) or complete remission with partial hematologic recovery (CRh).

secondary acute myeloid leukemia
cytarabine/daunorubicin
leukemia
daunorubicin
blast cells
Charit - Universit tsmedizin Berlin
 (8.8 away) Contact site
  • 116 views
  • 03 Jun, 2021
  • +40 other locations
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

This is a phase 1b/2, multicenter, open-label, basket trial to evaluate the safety of talimogene laherparepvec injected intrahepatically into liver tumors alone and in combination with systemic IV administration of pembrolizumab, in subjects with non-HCC liver metastases from BC, CRC, gastroesophageal cancer (GEC), melanoma, NSCLC, RCC in Part 1 Group …

breast cancer
liver metastasis
liver tumor
cancer
HER2
Research Site
 (8.8 away) Contact site
  • 0 views
  • 10 Jun, 2021
  • +64 other locations
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

The study is being done to test the safety of a cancer drug called larotrectinib in children. The cancer must have a change in a particular gene (NTRK1, NTRK2 or NTRK3). Larotrectinib blocks the actions of these NTRK genes in cancer cells and can therefore be used to treat cancer. …

breast cancer
metastatic solid tumor
primary cancer
solid tumor
metastasis
Charit Campus Virchow-Klinikum (CVK)
 (8.8 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +70 other locations
A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

This is a Phase 1/2, open-label, single arm, multicohort study to evaluate the safety and efficacy of JCAR017 in pediatric subjects aged 25 years with CD19+ r/r B-ALL and B-NHL. Phase 1 will identify a recommended Phase 2 dose (RP2D). Phase 2 will evaluate the efficacy of JCAR017 RP2D in …

fludarabine
ejection fraction
b-cell lymphoma
b-cell acute lymphoblastic leukemia
diffuse large b-cell lymphoma
Charite Campus Virchow
 (8.8 away) Contact site
  • 46 views
  • 11 May, 2021
  • +13 other locations